急诊环境下的急性心力衰竭管理共识
该共识文件总结了急诊环境(院前急救和急诊科)中急性心力衰竭的诊断、治疗和分流决策的当前证据与实践建议。强调快速表型分类为急性失代偿性心衰、急性肺水肿、孤立性右心室衰竭或心源性休克以指导早期管理和分诊,并回顾了生物标志物、影像、通气支持、利尿剂和血管扩张剂策略以及指南导向药物治疗的早期启动或继续使用等证据。
要点
- 快速表型分类为急性失代偿性心衰、急性肺水肿、孤立性右心室衰竭或心源性休克是指导早期管理和分诊的关键工具。
- 急诊管理证据包括生物标志物、影像、通气支持、利尿剂和血管扩张剂策略以及指南导向药物治疗的早期启动或继续使用。
- 使用经过验证的工具进行风险分层和分流决策。
核心结论
- 该共识文件旨在通过提供急诊环境下急性心力衰竭诊断、治疗和分流的实践建议,促进急性心力衰竭患者结局的改善。
研究设计与样本
- 这是一份共识文件,总结了当前证据并为急诊医生提供实践建议,涉及院前急救和急诊科环境。
主要发现
- 大多数急性心力衰竭患者就诊于急诊科,最初几小时的护理对决定预后至关重要。
- 部分患者在到达急诊科前已由院前急救医疗服务进行评估和治疗。
- 快速表型分类为急性失代偿性心衰、急性肺水肿、孤立性右心室衰竭或心源性休克是指导早期管理和分诊决策的关键工具。
临床怎么用
- 急诊医生应利用快速表型分类指导急性心力衰竭患者的早期管理和分诊决策。
- 考虑使用生物标志物、影像、通气支持、利尿剂和血管扩张剂策略以及早期启动或继续指南导向药物治疗。
- 使用经过验证的工具进行风险分层和分流决策。
局限性
- 该文件识别了主要的知识空白和未来研究重点,包括评估院前干预、生物标志物指导的治疗和早期启动疾病修饰治疗的实用性试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute heart failure (AHF) represents a major cause of emergency medical care worldwide and continues to carry a substantial burden of morbidity and mortality despite advances in chronic heart failure management. Most patients with AHF present to emergency departments (EDs), where the first hours of care are critical to determine prognosis. Of these, some have been previously evaluated and treated by prehospital emergency medical services before ED arrival. This consensus document summarizes the current evidence and provides practical advice to emergency physicians for the diagnosis, treatment, and disposition of patients with AHF in these emergency settings (emergency medical services and ED). It emphasizes the importance of a rapid phenotypic classification into acute decompensated heart failure, acute pulmonary oedema, isolated right ventricular failure, or cardiogenic shock, as a key tool to guide early management and triage decisions. It reviews evidence on prehospital and ED management, including the use of biomarkers, imaging, ventilatory support, diuretic and vasodilator strategies, and early initiation or continuation of guideline-directed medical therapy. It also discusses risk stratification and disposition decisions supported by validated tools. Finally, it identifies major knowledge gaps and future research priorities, including pragmatic trials to assess prehospital interventions, biomarker-guided therapy, and early initiation of disease-modifying treatments. Ultimately, this consensus document is aimed to contribute to the improvement of outcomes in AHF.
引用
- Miró, Masip, Chioncel, et al. Acute heart failure in emergency settings. Eur Heart J. 2026. PMID: 42906949. doi:10.1093/eurheartj/ehag744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。